Holocene Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-107,245
Closed -$1.31M 709
2023
Q2
$1.31M Buy
+107,245
New +$1.2M 0.01% 609
2022
Q3
Sell
-121,629
Closed -$2.19M 792
2022
Q2
$2.19M Buy
121,629
+217
+0.2% +$3.52K 0.01% 504
2022
Q1
$1.95M Buy
+121,412
New +$2.18M 0.01% 532
2021
Q4
Sell
-16,106
Closed -$375K 846
2021
Q3
$375K Sell
16,106
-10,156
-39% -$246K ﹤0.01% 764
2021
Q2
$720K Buy
+26,262
New +$749K ﹤0.01% 699

Other funds holding AHCO

Holocene Advisors's AHCO Position: Q3 2023 in Review

Holocene Advisors sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 107,245 shares — an estimated $1.31M sold.

Holocene Advisors first reported a position in AHCO in Q2 2021 and held it in 5 quarters. The position peaked at $2.19M in Q2 2022. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • Holocene Advisors reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
  • Holocene Advisors sold 107,245 AdaptHealth shares in Q3 2023, an estimated $1.31M.
  • Holocene Advisors first reported a position in AdaptHealth in Q2 2021 and held it in 5 quarters.
  • Holocene Advisors's AdaptHealth position peaked at $2.19M in Q2 2022.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on Holocene Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.